Literature DB >> 18216324

The puzzling role of TRAIL in endothelial cell biology.

Paola Secchiero, Giorgio Zauli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18216324     DOI： 10.1161/ATVBAHA.107.158451

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  8 in total

1.  The parallel lives of angiogenesis and immunosuppression: cancer and other tales.

Authors:  Gregory T Motz; George Coukos
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

Review 2.  Immunological hallmarks of stromal cells in the tumour microenvironment.

Authors:  Shannon J Turley; Viviana Cremasco; Jillian L Astarita
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

3.  TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.

Authors:  Jan-Bernd Funcke; Verena Zoller; Muad Abd El Hay; Klaus-Michael Debatin; Martin Wabitsch; Pamela Fischer-Posovszky
Journal:  FASEB J       Date:  2015-04-09       Impact factor: 5.191

Review 4.  Deciphering and reversing tumor immune suppression.

Authors:  Greg T Motz; George Coukos
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

Review 5.  Targeting the tumor vasculature to enhance T cell activity.

Authors:  Evripidis Lanitis; Melita Irving; George Coukos
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

Review 6.  Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Cancers (Basel)       Date:  2019-02-06       Impact factor: 6.639

7.  A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.

Authors:  Lana E Kandalaft; Cheryl L Chiang; Janos Tanyi; Greg Motz; Klara Balint; Rosemarie Mick; George Coukos
Journal:  J Transl Med       Date:  2013-06-18       Impact factor: 5.531

Review 8.  Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.

Authors:  Dmitriy Zamarin; Jedd D Wolchok
Journal:  Mol Ther Oncolytics       Date:  2014-12-10       Impact factor: 7.200
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.